FR07C0071I1 - - Google Patents

Info

Publication number
FR07C0071I1
FR07C0071I1 FR07C0071C FR07C0071I1 FR 07C0071 I1 FR07C0071 I1 FR 07C0071I1 FR 07C0071 C FR07C0071 C FR 07C0071C FR 07C0071 I1 FR07C0071 I1 FR 07C0071I1
Authority
FR
France
Prior art keywords
bacteria
infected cells
cells
attenuated
cultivate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27041284&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR07C0071(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/465,337 external-priority patent/US5714375A/en
Application filed filed Critical
Publication of FR07C0071I1 publication Critical patent/FR07C0071I1/fr
Application granted granted Critical
Publication of FR07C0071I2 publication Critical patent/FR07C0071I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
FR07C0071C 1995-06-05 2007-12-21 Culture de lawsonia intracellularis, vaccins anti-lawsonia intracellularis et agents de diagnostic Active FR07C0071I2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/465,337 US5714375A (en) 1995-06-05 1995-06-05 Ileal symbiont intracellularis propagation in suspended host cells
US08/658,194 US5885823A (en) 1995-06-05 1996-06-04 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
EP03022895.1A EP1403643B2 (en) 1995-06-05 1996-06-05 Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents
EP96921391.7A EP0843818B2 (en) 1995-06-05 1996-06-05 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents

Publications (2)

Publication Number Publication Date
FR07C0071I1 true FR07C0071I1 (es) 2008-01-02
FR07C0071I2 FR07C0071I2 (fr) 2010-12-31

Family

ID=27041284

Family Applications (1)

Application Number Title Priority Date Filing Date
FR07C0071C Active FR07C0071I2 (fr) 1995-06-05 2007-12-21 Culture de lawsonia intracellularis, vaccins anti-lawsonia intracellularis et agents de diagnostic

Country Status (24)

Country Link
US (1) US5885823A (es)
EP (5) EP1645567B2 (es)
JP (4) JP3765834B2 (es)
KR (4) KR20060129549A (es)
AT (3) ATE289069T1 (es)
AU (1) AU717045B2 (es)
BG (1) BG64292B1 (es)
BR (2) BRPI9612938B8 (es)
CA (1) CA2222643C (es)
CZ (1) CZ295933B6 (es)
DE (5) DE69638016D1 (es)
DK (3) DK1645567T4 (es)
ES (3) ES2173055T3 (es)
FR (1) FR07C0071I2 (es)
HK (1) HK1010911A1 (es)
HU (1) HU230199B1 (es)
LU (1) LU91405I2 (es)
NL (1) NL300331I2 (es)
NZ (1) NZ319994A (es)
PL (6) PL187849B1 (es)
PT (3) PT1403643E (es)
RO (1) RO118885B1 (es)
RU (2) RU2265849C2 (es)
WO (1) WO1996039629A1 (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1145697C (zh) 1995-11-30 2004-04-14 维多利亚农业服务控股公司 治疗和诊断组合物
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
CA2372098A1 (en) * 1999-05-13 2000-11-23 Pfizer Products Inc. Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
MXPA01011570A (es) * 1999-05-13 2003-08-20 Australian Pork Ltd Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con peptido h de membrana externa.
EP1177213A4 (en) * 1999-05-13 2002-08-28 Pfizer Prod Inc LAWSONIA DERIVATIVE GENE, POLYPEPTIDES, PEPTIDES AND HEMOLYSIN PROTEINS AND USES THEREOF
US7052697B1 (en) * 1999-05-13 2006-05-30 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
MXPA01011670A (es) * 1999-05-13 2003-10-14 Pfizer Prod Inc Gen derivado de lawsonia y polipeptidos, peptidos y proteinas sodc relacionadso y sus usos.
US7029683B1 (en) 1999-05-13 2006-04-18 Pfizer Products, Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
US6605696B1 (en) * 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
HUP0303655A2 (hu) * 2000-09-29 2004-03-01 Arizona Board Of Regents On Behalf Of The University Of Arizona Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk
JP2004512851A (ja) * 2000-11-10 2004-04-30 アグリカルチュア　ビクトリア　サービシーズプロプライエトリー　リミティッド ラウソニア種による感染を処置する新規な治療用組成物
AUPR138100A0 (en) 2000-11-10 2000-12-07 Agriculture Victoria Services Pty Ltd Novel therapeutic compositions for treating infection by lawsonia spp
DK1586646T3 (da) * 2000-12-20 2011-06-27 Intervet Int Bv Lawsonia intracellularis-vaccine
US20030087421A1 (en) * 2001-07-11 2003-05-08 Gebhart Connie J Lawsonia intracellularis
EP1570045A4 (en) * 2002-10-04 2007-09-05 Univ Minnesota NUCLEIC ACID AND POLYPEPTIDE SEQUENCES FROM LAWSONIA INTRACELLULARIS AND METHOD OF USE
PT1651260E (pt) * 2003-07-25 2009-09-24 Boehringer Ingelheim Vetmed Lawsonia intracellularis de origem europeia e vacinas, agentes de diagnóstico e métodos para sua utilização
US7662390B2 (en) 2003-09-12 2010-02-16 Intarvet International B.V. Lawsonia intracellularis subunit vaccine
BRPI0417440A (pt) * 2003-12-09 2007-03-06 Intervet Int Bv ácido nucleico, fragmento e molécula de dna, veìculo recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, vacina para combater as infecções com lawsonia intracelularis, método para a preparação de uma vacina, e, testes de diagnóstico para aldetecção de anticorpos contra lawsonia intracellularis e material antigênico de lawsonia intracellularis
MXPA06008217A (es) * 2004-01-22 2007-05-23 Intervet Int Bv Vacunas con subunidad de lawsonia intracellularis.
EP1609870A1 (en) * 2004-06-24 2005-12-28 Boehringer Ingelheim Vetmedica Gmbh Method of diagnosing lawsonia intracellularis
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
US20060021536A1 (en) * 2004-07-30 2006-02-02 Limin Song Method for creating an absorbent article exhibiting a harmonic color scheme
KR100621882B1 (ko) * 2004-09-30 2006-09-19 건국대학교 산학협력단 돼지 증식성 회장염 감염돈에서 로소니아인트라셀룰라리스 균을 분리하는 방법
AU2005308583A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Methods for cultivating Lawsonia intracellularis
US20070212373A1 (en) * 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
CN109125721A (zh) 2005-12-29 2019-01-04 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2免疫原性组合物用于减轻猪临床症状的用途
BR122015028489B1 (pt) 2005-12-29 2021-10-13 Boehringer Ingelheim Animal Health Usa Inc Vacina de combinação multivalente contra pcv2, bem como uso de uma proteína orf2 na preparação da mesma
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
WO2008073464A2 (en) * 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
ES2726777T3 (es) 2006-12-15 2019-10-09 Boehringer Ingelheim Animal Health Usa Inc Vacuna porcina anti-PCV2 en dosis única
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
WO2009037262A2 (en) * 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
CN101874106A (zh) * 2007-10-12 2010-10-27 辉瑞大药厂 培养胞内劳森氏菌的方法
KR20100103535A (ko) * 2007-12-31 2010-09-27 베링거잉겔하임베트메디카인코퍼레이티드 외래 아미노산 삽입물을 갖는 ｐｃｖ２ ｏｒｆ２ 바이러스 유사 입자
CA2712006A1 (en) 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
EP2254595A4 (en) * 2008-02-15 2012-12-05 Boehringer Ingelheim Vetmed METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
EP2318041B1 (en) 2008-07-22 2015-02-25 Intervet International BV Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
WO2011006880A1 (en) * 2009-07-14 2011-01-20 Intervet International B.V. Lawsonia intracellularis propagation
AR078253A1 (es) * 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
US8530223B2 (en) * 2009-11-09 2013-09-10 Intervet International B.V. Method to grow Lawsonia intracellularis bacteria in persistently infected McCoy cells
CN108379571A (zh) 2012-12-28 2018-08-10 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法
EP4091629A1 (en) 2013-09-25 2022-11-23 Zoetis Services LLC Pcv2b divergent vaccine composition and methods of use
US9505808B2 (en) 2013-10-02 2016-11-29 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 protein variant and virus like particles composed thereof
CN107206062B (zh) 2015-02-04 2021-07-02 英特维特国际股份有限公司 用于针对猪中亚临床劳森氏菌感染的疫苗
RU2709197C2 (ru) 2015-02-04 2019-12-17 Интервет Интернэшнл Б.В. Вакцина для применения против субклинической инфекции lawsonia у свиней
KR20180062468A (ko) * 2016-11-18 2018-06-11 녹십자수의약품(주) 신규한 로소니아 인트라셀룰라리스 균주 및 이의 용도
CA3088651A1 (en) 2018-02-28 2019-09-06 Boehringer Ingelheim Vetmedica Gmbh Method for reducing skatole and/or indole in animals
CA3185751A1 (en) 2020-07-24 2022-01-27 Edgar DIAZ Combination porcine vaccine
AU2022375120A1 (en) 2021-11-01 2024-04-11 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions
WO2024068637A1 (en) * 2022-09-27 2024-04-04 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132597A (en) * 1976-06-09 1979-01-02 Ab Medipharm Method for cultivation of bacteria
US4237218A (en) * 1979-02-09 1980-12-02 Bio-Rad Laboratories, Inc. Micro-carrier cell culture
JPS5991879A (ja) * 1982-11-16 1984-05-26 Hideaki Yamada シユ−ドモナス属細菌の培養法
DK594084A (da) * 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
JPH0644865B2 (ja) * 1985-10-29 1994-06-15 三菱瓦斯化学株式会社 カンピロバクタ−属細菌の培養方法
US5338670A (en) * 1986-07-28 1994-08-16 The United States Of America As Represented By The Department Of Health And Human Services Production of bordetella pertussis toxin with a low concentration of iron
IT1227657B (it) * 1988-12-01 1991-04-23 Mini Ricerca Scient Tecnolog Antibiotici ab-021 e processo per la loro produzione
JPH0822221B2 (ja) * 1988-12-28 1996-03-06 日東化学工業株式会社 シュードモナス属細菌の培養法
JPH02308754A (ja) * 1989-05-24 1990-12-21 Yakult Honsha Co Ltd 乳発酵食品の製造法
US5296221A (en) * 1990-01-31 1994-03-22 Sani-Ei Sucrochemical Co., Ltd. Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations
ES2150419T3 (es) * 1990-11-01 2000-12-01 Univ Iowa State Res Found Inc Procedimiento de atenuacion bacteriana y vacuna.
ES2194841T3 (es) * 1991-11-15 2003-12-01 Pfizer Procedimiento de produccion de vacunas bacterianas gram negativas.
DE4208785A1 (de) * 1992-03-19 1993-09-23 Degussa Verfahren zum auffinden von insertionselementen (is-elemente) oder transposonen
US5610059A (en) * 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis

Also Published As

Publication number Publication date
CZ295933B6 (cs) 2005-12-14
DE122007000102I1 (de) 2008-04-17
RU2265849C2 (ru) 2005-12-10
JP2008266340A (ja) 2008-11-06
RO118885B1 (ro) 2003-12-30
DE69634334T2 (de) 2006-04-13
EP1403643A1 (en) 2004-03-31
DK1645567T4 (en) 2016-04-11
JP2006061165A (ja) 2006-03-09
NL300331I1 (nl) 2008-03-03
JP4263212B2 (ja) 2009-05-13
EP1403643B1 (en) 2009-09-02
BRPI9612938B1 (pt) 2010-07-27
PL325872A1 (en) 1998-08-17
ES2332587T3 (es) 2010-02-09
RU2005114739A (ru) 2006-11-20
PL187849B1 (pl) 2004-10-29
JP3765834B2 (ja) 2006-04-12
EP0843818B2 (en) 2018-12-19
BRPI9612938B8 (pt) 2017-09-12
ES2173055T3 (es) 2005-07-01
MX9709464A (es) 1998-06-30
NZ319994A (en) 2000-01-28
KR20060129549A (ko) 2006-12-15
AU6262796A (en) 1996-12-24
EP0843818B1 (en) 2005-02-09
EP1645567A1 (en) 2006-04-12
EP1655607B1 (en) 2015-05-13
BG102130A (en) 1998-09-30
BR9608338A (pt) 1999-01-05
EP0843818A4 (en) 2002-02-06
CA2222643A1 (en) 1996-12-12
HUP9900884A2 (hu) 1999-07-28
KR20050046741A (ko) 2005-05-18
EP0843818A1 (en) 1998-05-27
DE69637251T2 (de) 2008-06-12
ES2173055T1 (es) 2002-10-16
EP1403643B2 (en) 2018-10-03
EP2199795A2 (en) 2010-06-23
DE69638016D1 (de) 2009-10-15
EP1645567B1 (en) 2007-09-12
JPH11507225A (ja) 1999-06-29
CA2222643C (en) 2013-08-13
EP2199795B1 (en) 2016-03-30
PL189286B1 (pl) 2005-07-29
KR100544857B1 (ko) 2006-01-24
BG64292B1 (bg) 2004-08-31
PT1403643E (pt) 2009-10-08
RU2305707C2 (ru) 2007-09-10
JP5078740B2 (ja) 2012-11-21
PL189250B1 (pl) 2005-07-29
ES2294620T5 (es) 2016-03-23
PL189187B1 (pl) 2005-07-29
FR07C0071I2 (fr) 2010-12-31
EP2199795A3 (en) 2010-11-03
DE69634334D1 (de) 2005-03-17
ATE373015T1 (de) 2007-09-15
ATE441863T1 (de) 2009-09-15
DK1403643T3 (da) 2010-01-04
DK1645567T3 (da) 2007-11-26
KR20050048651A (ko) 2005-05-24
EP1645567B2 (en) 2016-01-06
AU717045B2 (en) 2000-03-16
DE69637251T3 (de) 2016-06-02
NL300331I2 (nl) 2008-07-01
US5885823A (en) 1999-03-23
JP3920300B2 (ja) 2007-05-30
PL189287B1 (pl) 2005-07-29
BR9608338B1 (pt) 2009-05-05
HK1010911A1 (en) 1999-07-02
ES2294620T3 (es) 2008-04-01
HU230199B1 (hu) 2015-10-28
PL187850B1 (pl) 2004-10-29
PT843818E (pt) 2005-04-29
ATE289069T1 (de) 2005-02-15
LU91405I2 (fr) 2008-02-21
WO1996039629A1 (en) 1996-12-12
JP2007151554A (ja) 2007-06-21
HUP9900884A3 (en) 2001-01-29
DK0843818T3 (da) 2005-05-09
PT1645567E (pt) 2007-11-19
KR100513481B1 (ko) 2006-01-27
KR19990022509A (ko) 1999-03-25
EP1655607A1 (en) 2006-05-10
KR100758614B1 (ko) 2007-09-13
DE69637251D1 (de) 2007-10-25
DE843818T1 (de) 2002-11-28
CZ389997A3 (cs) 1998-07-15

Similar Documents

Publication Publication Date Title
ES2294620T5 (es) Cultivo de Lawsonia intracellularis, vacunas anti-Lawsonia intracellularis y agentes de diagnóstico
Newton et al. Isolation of cyanobacteria from the aquatic fern, Azolla
JPS5758884A (en) Preparation of glutathione peroxidase
MY134726A (en) Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
JPS5743685A (en) L-glutamic oxidase
AU634148B2 (en) Use of cellulase preparations in the cultivation and use of cellulose-producing microorganisms
JPS5743684A (en) Preparation of maltose dehydrogenase
KR970064356A (ko) 버섯류의 재배방법
JPS57132880A (en) Preparation of choline oxidase by fermentation method
JPS6474976A (en) Short-period 'sanpai' yeast culture using thermostable lactic acid bacteria
JPS5651989A (en) Preparation of l-valine by fermentation method
JPS57141289A (en) Preparation of amine oxidase
JPS56106590A (en) Preparation of galactose oxidase
JPS57206386A (en) Preparation of ethanolamine oxidase
JPS56106589A (en) Preparation of glutathione reductase
GR3004110T3 (es)
TH112991B (th) การเลี้ยง Lawsonia intracellularis วัคซีนต้าน Lawsonia intracellluris และสารสำหรับใช้วินิจฉัย
JPS5786292A (en) Preparation of n-benzoyl-l-alanine acylase